OMD was defined as 1–5 (progressing) metastases detected using CT and/or bone scan, MRI, or PET-CT with choline, fluciclovine, or PSMA tracers, with some variations in restrictions on metastatic sites and the number of metastases per organ. The gene discussed is FOLH1; the disease is occult macular dystrophy.